ADIPOQ and metabolic syndrome: The mechanism was proposed as followed[8]: increased adiposity tissue in metabolic syndrome could engender increasing secretions of adipokines and cytokines such as leptin, adiponectin, interleukin 6, and tumor necrosis factor α, which could lead to chronic low-grade inflammation and increase PLT counts.